Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Olanzapine augmentation of fluoxetine in body dysmorphic disorder.

Literature DB >> 15863817

Olanzapine augmentation of fluoxetine in body dysmorphic disorder.

Katharine A Phillips.

Abstract

Entities: Chemical Disease

Mesh：

Substances：

Year: 2005 PMID： 15863817 PMCID： PMC1613796 DOI： 10.1176/appi.ajp.162.5.1022-a

Source DB: PubMed Journal: Am J Psychiatry ISSN： 0002-953X Impact factor: 18.112

× No keyword cloud information.

5 in total

1. Effectiveness of pharmacotherapy for body dysmorphic disorder: a chart-review study.

Authors: K A Phillips; R S Albertini; J M Siniscalchi; A Khan; M Robinson
Journal: J Clin Psychiatry Date: 2001-09 Impact factor: 4.384

2. Successful treatment of nondelusional body dysmorphic disorder with olanzapine: a case report.

Authors: J E Grant
Journal: J Clin Psychiatry Date: 2001-04 Impact factor: 4.384

3. A severity rating scale for body dysmorphic disorder: development, reliability, and validity of a modified version of the Yale-Brown Obsessive Compulsive Scale.

Authors: K A Phillips; E Hollander; S A Rasmussen; B R Aronowitz; C DeCaria; W K Goodman
Journal: Psychopharmacol Bull Date: 1997

4. Clomipramine vs desipramine crossover trial in body dysmorphic disorder: selective efficacy of a serotonin reuptake inhibitor in imagined ugliness.

Authors: E Hollander; A Allen; J Kwon; B Aronowitz; J Schmeidler; C Wong; D Simeon
Journal: Arch Gen Psychiatry Date: 1999-11

5. Placebo-controlled study of pimozide augmentation of fluoxetine in body dysmorphic disorder.

Authors: Katharine A Phillips
Journal: Am J Psychiatry Date: 2005-02 Impact factor: 18.112

5 in total

12 in total

Review 1. Should an obsessive-compulsive spectrum grouping of disorders be included in DSM-V?

Authors: Katharine A Phillips; Dan J Stein; Scott L Rauch; Eric Hollander; Brian A Fallon; Arthur Barsky; Naomi Fineberg; David Mataix-Cols; Ygor Arzeno Ferrão; Sanjaya Saxena; Sabine Wilhelm; Megan M Kelly; Lee Anna Clark; Anthony Pinto; O Joseph Bienvenu; Joanne Farrow; James Leckman
Journal: Depress Anxiety Date: 2010-06 Impact factor: 6.505

Review 2. Body dysmorphic disorder: some key issues for DSM-V.

Authors: Katharine A Phillips; Sabine Wilhelm; Lorrin M Koran; Elizabeth R Didie; Brian A Fallon; Jamie Feusner; Dan J Stein
Journal: Depress Anxiety Date: 2010-06 Impact factor: 6.505

3. Pharmacotherapy for body dysmorphic disorder: treatment received and illness severity.

Authors: Katharine A Phillips; Maria E Pagano; William Menard
Journal: Ann Clin Psychiatry Date: 2006 Oct-Dec Impact factor: 1.567

4. Obsessive-compulsive disorder after body dysmorphic disorder: a report of 2 cases (a man and his mother).

Authors: Fatih Canan; Emel Kocer; Salih Yildirim; Ahmet Ataoglu
Journal: Prim Care Companion J Clin Psychiatry Date: 2007

5. Associations in the longitudinal course of body dysmorphic disorder with major depression, obsessive-compulsive disorder, and social phobia.

Authors: Katharine A Phillips; Robert L Stout
Journal: J Psychiatr Res Date: 2005-11-23 Impact factor: 4.791

Review 10. Body dysmorphic disorder.

Authors: Andri S Bjornsson; Elizabeth R Didie; Katharine A Phillips
Journal: Dialogues Clin Neurosci Date: 2010 Impact factor: 5.986